Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 Vaccines: Adenoviral Vectors
Catherine Jacob-Dolan, Dan H. Barouch
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 41-54
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Viral Vector-Based Gene Therapy
Xuedan Li, Yang Le, Zhegang Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7736-7736
Open Access | Times Cited: 85
Viral Vectors for the in Vivo Delivery of CRISPR Components: Advances and Challenges
Misganaw Asmamaw Mengstie
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 78
Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy
Seyed Esmaeil Ahmadi, Maral Soleymani, Fahimeh Shahriyary, et al.
Cancer Gene Therapy (2023) Vol. 30, Iss. 7, pp. 936-954
Open Access | Times Cited: 50
Immunogenicity of CRISPR therapeutics—Critical considerations for clinical translation
Radwa Ewaisha, Karen S. Anderson
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 39
Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 Vaccines
Tomabu Adjobimey, Julia Meyer, Leander Sollberg, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 51
Adjuvants for COVID-19 Vaccines
Javier Castrodeza, Ivan Sanz‐Muñoz, José María Eirós Bouza
Vaccines (2023) Vol. 11, Iss. 5, pp. 902-902
Open Access | Times Cited: 25
Construction and application of adenoviral vectors
Hongbo Zhang, Hongdan Wang, Youcai An, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 34, pp. 102027-102027
Open Access | Times Cited: 23
Incidence and management of the main serious adverse events reported after COVID‐19 vaccination
Teresa Padilla‐Flores, Alicia Sampieri, Luis Vaca
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 9
SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs
Sho Iketani, David D. Ho
Cell chemical biology (2024) Vol. 31, Iss. 4, pp. 632-657
Open Access | Times Cited: 7
Recombinant vaccines in 2022: a perspective from the cell factory
Marianna Teixeira de Pinho Favaro, Jan Atienza-Garriga, Carlos Martínez-Torró, et al.
Microbial Cell Factories (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 27
Viral Vectors, Exosomes, and Vexosomes: Potential armamentarium for delivering CRISPR/Cas to cancer cells
Mahdieh Farzanehpour, Ali Miri, Akbar Ghorbani Alvanegh, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115555-115555
Closed Access | Times Cited: 16
Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2
Marta Giovanetti, Francesco Branda, Eleonora Cella, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Open Access | Times Cited: 15
Plattformtechnologien in der Impfstoffentwicklung
Eberhard Hildt
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2025)
Open Access
Protection of Novel Adenovirus Vectored Vaccine in Rats Against Wild‐Type Hepacivirus and Variant Infections
Shengxue Luo, Qitao Deng, Chaolan Liang, et al.
Liver International (2025) Vol. 45, Iss. 4
Closed Access
Pathological and protective roles of dendritic cells in Mycobacterium tuberculosis infection: Interaction between host immune responses and pathogen evasion
Hongmin Kim, Sung Jae Shin
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 24
Molecular Mechanisms of the Medicines for COVID-19
Makoto Komiyama
Bulletin of the Chemical Society of Japan (2022) Vol. 95, Iss. 9, pp. 1308-1317
Closed Access | Times Cited: 23
COVID-19 vaccines and the pandemic: lessons learnt for other neglected diseases and future threats
Peter J. Hotez, Sarah C. Gilbert, Mélanie Saville, et al.
BMJ Global Health (2023) Vol. 8, Iss. 6, pp. e011883-e011883
Open Access | Times Cited: 13
Eco-Friendly Cellulose-Based Nonionic Antimicrobial Polymers with Excellent Biocompatibility, Nonleachability, and Polymer Miscibility
Xugang Dang, Zhenfu Yu, Xuechuan Wang, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 43, pp. 50344-50359
Closed Access | Times Cited: 12
SARS-CoV-2 infection and immune responses
Rakhi Harne, Brittany Williams, Hazem F. M. Abdelaal, et al.
AIMS Microbiology (2023) Vol. 9, Iss. 2, pp. 245-276
Open Access | Times Cited: 11
Vaccine development against tuberculosis before and after Covid-19
Stefan H. E. Kaufmann
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov
Shenyu Wang, Wenqing Liu, Yuqing Li, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 704-713
Open Access | Times Cited: 10
pGM-CSF as an adjuvant in DNA vaccination against SARS-CoV-2
Chang Liu, Ruo‐Yi Xue, Guocheng Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130660-130660
Closed Access | Times Cited: 3
Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
Nicholas M. Provine, Paul Klenerman
European Journal of Immunology (2022) Vol. 53, Iss. 6
Open Access | Times Cited: 17
Comparative analysis of the impact of 40 adenovirus types on dendritic cell activation and CD8+ T cell proliferation capacity for the identification of favorable immunization vector candidates
Xiaoyan Wang, Mario Hetzel, Wenli Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
CRISPR/CAS as a Powerful Tool for Human Immunodeficiency Virus Cure: A Review
Shirley Vasconcelos Komninakis, Wilson Domingues, Sabri Saeed Sanabani, et al.
AIDS Research and Human Retroviruses (2024) Vol. 40, Iss. 6, pp. 363-375
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top